Characterization of oxaliplatin-induced chronic painful peripheral neuropathy in the rat and comparison with the neuropathy induced by paclitaxel.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Neuroscience

• Publication date

  2012-02-17

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.neuroscience.2011.12.023PMID 22200546PMCID PMC3273641
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neurotoxic Complications of Chemotherapy in Patients with Cancer

  2012cited by this paper
• Effects of mitochondrial poisons on the neuropathic pain produced by the chemotherapeutic agents, paclitaxel and oxaliplatin

  2012cited by this paper
• Allopregnanolone prevents and suppresses oxaliplatin‐evoked painful neuropathy: Multi‐parametric assessment and direct evidence

  2011influential reference
• Proteinase-activated receptor 2 sensitizes transient receptor potential vanilloid 1, transient receptor potential vanilloid 4, and transient receptor potential ankyrin 1 in paclitaxel-induced neuropathic pain.

  2011influential reference
• Peroxynitrite decomposition catalyst blocks paclitaxel-induced neuropathic pain: microarray analysis of spinal cord gene expression

  2011cited by this paper
• Mitochondrial abnormality in sensory, but not motor, axons in paclitaxel-evoked painful peripheral neuropathy in the rat.

  2011cited by this paper
• Oxaliplatin-induced cold hypersensitivity is due to remodelling of ion channel expression in nociceptors

  2011cited by this paper
• Natural history of paclitaxel-associated acute pain syndrome: prospective cohort study NCCTG N08C1.

  2011cited by this paper
• Protection against oxaliplatin-induced mechanical hyperalgesia and intraepidermal nerve fiber loss by minocycline.

  2011cited by this paper
• Oxaliplatin elicits mechanical and cold allodynia in rodents via TRPA1 receptor stimulation

  2011influential reference
• Multimodal assessment of painful peripheral neuropathy induced by chronic oxaliplatin-based chemotherapy in mice

  2011cited by this paper
• Muscle pain in models of chemotherapy‐induced and alcohol‐induced peripheral neuropathy

  2011cited by this paper
• Functional deficits in peripheral nerve mitochondria in rats with paclitaxel- and oxaliplatin-evoked painful peripheral neuropathy.

  2011cited by this paper
• Chronic treatment-related pain in cancer survivors.

  2011cited by this paper
• Terminal arbor degeneration – a novel lesion produced by the antineoplastic agent paclitaxel

  2011cited by this paper
• Urinary excretion of carnitine as a marker of proximal tubular damage associated with platin-based antineoplastic drugs.

  2010cited by this paper
• Transient Receptor Potential Vanilloid 1 is essential for cisplatin-induced heat hyperalgesia in mice

  2010cited by this paper
• Oxaliplatin‐induced neuropathy in the rat: Involvement of oxalate in cold hyperalgesia but not mechanical allodynia

  2009influential reference
• Direct inhibition of the mitochondrial permeability transition pore: a possible mechanism for better neuroprotective effects of allopregnanolone over progesterone.

  2009cited by this paper
• Olesoxime (cholest‐4‐en‐3‐one, oxime): Analgesic and neuroprotective effects in a rat model of painful peripheral neuropathy produced by the chemotherapeutic agent, paclitaxel

  2009cited by this paper
• Comparison of oxaliplatin- and cisplatin-induced painful peripheral neuropathy in the rat.

  2009cited by this paper
• Mice with cisplatin and oxaliplatin-induced painful neuropathy develop distinct early responses to thermal stimuli

  2009influential reference
• Chemotherapy‐evoked neuropathic pain: Abnormal spontaneous discharge in A‐fiber and C‐fiber primary afferent neurons and its suppression by acetyl‐l‐carnitine

  2008cited by this paper
• Comparative antiallodynic activity of morphine, pregabalin and lidocaine in a rat model of neuropathic pain produced by one oxaliplatin injection.

  2008cited by this paper
• C‐fiber spontaneous discharge evoked by chronic inflammation is suppressed by a long‐term infusion of lidocaine yielding nanogram per milliliter plasma levels

  2008cited by this paper
• Oxaliplatin acts on IB4-positive nociceptors to induce an oxidative stress-dependent acute painful peripheral neuropathy.

  2008cited by this paper
• Prevention of paclitaxel-evoked painful peripheral neuropathy by acetyl-L-carnitine: effects on axonal mitochondria, sensory nerve fiber terminal arbors, and cutaneous Langerhans cells.

  2008cited by this paper
• Chemotherapy‐induced neuropathy

  2008influential reference
• A review on oxaliplatin-induced peripheral nerve damage.

  2008influential reference
• Specific Antinociceptive Activity of Cholest-4-en-3-one, Oxime (TRO19622) in Experimental Models of Painful Diabetic and Chemotherapy-Induced Neuropathy

  2008influential reference
• Behavioral and immunohistological assessment of painful neuropathy induced by a single oxaliplatin injection in the rat.

  2007influential reference
• Dysfunction in multiple primary afferent fiber subtypes revealed by quantitative sensory testing in patients with chronic vincristine-induced pain.

  2007cited by this paper
• Uremic neuropathy: Clinical features and new pathophysiological insights

  2007influential reference
• Identification and Characterization of Cholest-4-en-3-one, Oxime (TRO19622), a Novel Drug Candidate for Amyotrophic Lateral Sclerosis

  2007influential reference
• Behavioral and pharmacological description of oxaliplatin‐induced painful neuropathy in rat

  2007influential reference
• Persistent Low-frequency Spontaneous Discharge in A-fiber and C-fiber Primary Afferent Neurons during an Inflammatory Pain Condition

  2007cited by this paper
• Peripheral neuropathy due to paclitaxel: study of the temporal relationships between the therapeutic schedule and the clinical quantitative score (QST) and comparison with neurophysiological findings

  2007cited by this paper
• Pain in oxaliplatin-induced neuropathy--sensitisation in the peripheral and central nociceptive system.

  2007influential reference
• Acetyl-L-carnitine prevents and reduces paclitaxel-induced painful peripheral neuropathy.

  2006cited by this paper
• Paclitaxel- and vincristine-evoked painful peripheral neuropathies: loss of epidermal innervation and activation of Langerhans cells.

  2006cited by this paper
• Clinical and experimental findings in humans and animals with chemotherapy-induced peripheral neuropathy.

  2006influential reference
• Studies of peripheral sensory nerves in paclitaxel‐induced painful peripheral neuropathy: Evidence for mitochondrial dysfunction

  2006cited by this paper
• Persistence of High-Dose Oxaliplatin-Induced Neuropathy at Long-Term Follow-Up

  2006influential reference
• Effects of Metabolic Modifiers Such as Carnitines, Coenzyme Q10, and PUFAs against Different Forms of Neurotoxic Insults: Metabolic Inhibitors, MPTP, and Methamphetamine

  2005influential reference
• Oxaliplatin‐induced neurotoxicity and the development of neuropathy

  2005influential reference
• Oxaliplatin-Associated Neuropathy: A Review

  2005cited by this paper
• Oxaliplatin causes selective atrophy of a subpopulation of dorsal root ganglion neurons without inducing cell loss

  2005influential reference
• Chemotherapy-induced peripheral neuropathy.

  2005influential reference
• Renal toxicity of oxaliplatin.

  2005cited by this paper
• Oxaliplatin induces hyperexcitability at motor and autonomic neuromuscular junctions through effects on voltage‐gated sodium channels

  2005cited by this paper
• Acetyl-L-Carnitine prevents and reverts experimental chronic neurotoxicity induced by oxaliplatin, without altering its antitumor properties.

  2005cited by this paper
• Reply to Dr

  2004influential reference
• Ethosuximide reverses paclitaxel‐ and vincristine‐induced painful peripheral neuropathy

  2004cited by this paper
• Taxol‐induced sensory disturbance is characterized by preferential impairment of myelinated fiber function in cancer patients

  2004cited by this paper
• Abeta-fiber nociceptive primary afferent neurons: a review of incidence and properties in relation to other afferent A-fiber neurons in mammals.

  2004cited by this paper
• Delaying the Mitochondrial Decay of Aging with Acetylcarnitine

  2004influential reference
• Altered temporal pattern of evoked afferent activity in a rat model of vincristine-induced painful peripheral neuropathy.

  2003cited by this paper
• Chemotherapy-induced peripheral neuropathy

  2002cited by this paper
• Role of protein kinase Cϵ and protein kinase A in a model of paclitaxel-induced painful peripheral neuropathy in the rat

  2001cited by this paper
• A possible explanation for a neurotoxic effect of the anticancer agent oxaliplatin on neuronal voltage-gated sodium channels.

  2001cited by this paper
• Nucleolar damage correlates with neurotoxicity induced by different platinum drugs

  2001cited by this paper
• A painful peripheral neuropathy in the rat produced by the chemotherapeutic drug, paclitaxel

  2001cited by this paper
• Effects of different schedules of oxaliplatin treatment on the peripheral nervous system of the rat.

  2001influential reference
• Activating transcription factor 3 (ATF3) induction by axotomy in sensory and motoneurons: A novel neuronal marker of nerve injury.

  2000influential reference
• Pharmacokinetics of oxaliplatin in patients with normal versus impaired renal function

  2000cited by this paper
• The chemotherapeutic oxaliplatin alters voltage-gated Na(+) channel kinetics on rat sensory neurons.

  2000cited by this paper
• Nociceptor Hyper-Responsiveness during Vincristine-Induced Painful Peripheral Neuropathy in the Rat

  1998cited by this paper
• Comparative neurotoxicity of oxaliplatin, cisplatin, and ormaplatin in a Wistar rat model.

  1998cited by this paper
• Evaluation of kidney and liver subacute toxicity of antitumor agents using serum biochemical parameters in rats.

  1993cited by this paper
• Sensory neurons of the rat sciatic nerve.

  1991cited by this paper
• Reply to Dr. Hirata and his colleagues

  1990cited by this paper
• Reply to Dr. Hirata and his colleagues

  1990influential reference
• A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia

  1987influential reference
• Stimulation-associated changes in frog neuromuscular junctions. A quantitative ultrastructural comparison of rapid-frozen and chemically fixed nerve terminals.

  1986cited by this paper
• Cisplatin nephrotoxicity.

  1986cited by this paper
• Motoneurons of the rat sciatic nerve.

  1986cited by this paper
• Ethical guidelines for investigations of experimental pain in conscious animals.

  1983influential reference

• Marine natural product-inspired 2-(3,4,5-trimethoxybenzoyl)quinazolin-4(3H)-one derivative CHNQD-01522: A novel anti-hepatocellular carcinoma agent targeting colchicine binding site of microtubule.

  2026cites this paper
• Lycium Barbarum Polysaccharide‐based Hydrogel as a Novel Oral Colon‐Targeted Drug Delivery System for Enhanced MSS‐CRC Treatment by Macrophage Lipid Reprogramming

  2026cites this paper
• Mechanisms and treatment of cancer therapy-induced peripheral and central neurotoxicity

  2025cites this paper
• 2016 Foundation for Peripheral Neuropathy International Research Symposium: Advances in Neuropathy ‐ Emerging Therapies

  2025cites this paper
• Mitochondrial dysfunction/hyperfunction inducing excessive mtROS in inflammatory and neuropathic pain

  2025cites this paper
• Antihyperalgesic Activity of Propoxazepam in the Oxaliplatin-Induced Cold Allodynia in Rats

  2025influential citation
• Chronic Oxaliplatin Treatment Induces CIPN in Mice via Activation of the TXNIP Pathway

  2025cites this paper
• Plant food-derived antioxidant nutrients in neuroprotection against chemotherapy-induced neurotoxicity: from molecular mechanisms to clinical applications

  2025cites this paper
• Endothelial glycocalyx in the peripheral capillaries is injured under oxaliplatin-induced neuropathy.

  2024cites this paper
• A novel marine‐derived mitophagy inducer ameliorates mitochondrial dysfunction and thermal hypersensitivity in paclitaxel‐induced peripheral neuropathy

  2024cites this paper
• Protective effects of Boswellia and Curcuma extract on oxaliplatin-induced neuropathy via modulation of NF-κB signaling

  2024cites this paper
• Targeting therapy-induced senescence as a novel strategy to combat chemotherapy-induced peripheral neuropathy

  2024cites this paper
• Signaling Pathways Concerning Mitochondrial Dysfunction: Implications in Neurodegeneration and Possible Molecular Targets

  2024cites this paper
• Prazosin as an Adjuvant to Increase Effectiveness of Duloxetine in a Rat Model of Oxaliplatin-Induced Peripheral Neuropathy

  2024cites this paper
• Mitochondrial A3 Adenosine Receptor as a Mechanism for the Protective Effects of A3AR Agonists on Chemotherapy-Induced Neuropathic Pain

  2024cites this paper
• Current understanding of the molecular mechanisms of chemotherapy-induced peripheral neuropathy

  2024cites this paper
• Intrathecal lactate dehydrogenase A inhibitors FX11 and oxamate alleviate chronic constriction injury-induced nociceptive sensitization through neuroinflammation and angiogenesis

  2024cites this paper
• Centralizing the Knowledge and Interpretation of Pain in Chemotherapy-Induced Peripheral Neuropathy: A Paradigm Shift towards Brain-Centric Approaches

  2024cites this paper
• Humanin Attenuates Metabolic, Toxic, and Traumatic Neuropathic Pain in Mice by Protecting Against Oxidative Stress and Increasing Inflammatory Cytokine.

  2024cites this paper
• Effectiveness of Duloxetine on Oxaliplatin-induced Allodynia and Hyperalgesia in Rats

  2023cites this paper
• Acetyl-L-carnitine for the prevention of taxane-induced neuropathy in patients with breast cancer: a systematic review and meta-analysis

  2023cites this paper
• PGC1α: an emerging therapeutic target for chemotherapy-induced peripheral neuropathy

  2023cites this paper
• Soluble epoxide hydrolase inhibition alleviates chemotherapy induced neuropathic pain

  2023cites this paper
• Naturally Inspired Molecules for Neuropathic Pain Inhibition—Effect of Mirogabalin and Cebranopadol on Mechanical and Thermal Nociceptive Threshold in Mice

  2023cites this paper
• Mitotherapy prevents peripheral neuropathy induced by oxaliplatin in mice.

  2023cites this paper
• Impaired microvascular reactivity in patients treated with 5-fluorouracil chemotherapy regimens: Potential role of endothelial dysfunction

  2023cites this paper
• Chalcones: An insight into their anticancer potential and action mechanism

  2023cites this paper
• Paclitaxel Induces Neurotoxicity by Disrupting Tricarboxylic Acid Cycle Metabolic Balance in the Mouse Hippocampus

  2023cites this paper
• Efficacy of metformin in prevention of paclitaxel-induced peripheral neuropathy in breast cancer patients: a randomized controlled trial

  2023cites this paper
• Novel GPR18 Ligands in Rodent Pharmacological Tests: Effects on Mood, Pain, and Eating Disorders

  2023cites this paper
• Antioxidant and Neuroprotective Effect of a Grape Pomace Extract on Oxaliplatin-Induced Peripheral Neuropathy in Rats: Biochemical, Behavioral and Histopathological Evaluation

  2022cites this paper
• Acylcarnitines: Nomenclature, Biomarkers, Therapeutic Potential, Drug Targets, and Clinical Trials

  2022cites this paper
• Fingolimod for treatment and or prevention of chemotherapy-induced peripheral neuropathy in humans?

  2022cites this paper
• Neuroprotective Effect of Baicalein Against Oxaliplatin-Induced Peripheral Neuropathy: Impact on Oxidative Stress, Neuro-inflammation and WNT/β-Catenin Signaling

  2022cites this paper
• Effect of Andrographolide and Resveratrol on OX1R and Prepro-orexin mRNA expression in CIPN-induced hypothalamus of mice with oxaliplatin

  2022cites this paper
• The Effects of Nuclear Factor Erythroid 2 (NFE2)-Related Factor 2 (Nrf2) Activation in Preclinical Models of Peripheral Neuropathic Pain

  2022cites this paper
• Mechanisms of Chemotherapy-Induced Neurotoxicity

  2022cites this paper
• Protective Mechanism of Electroacupuncture on Peripheral Neurotoxicity Induced by Oxaliplatin in Rats

  2022cites this paper
• Protective effect of a mitochondria‐targeting peptide against paclitaxel‐induced peripheral neuropathy

  2022cites this paper
• Chemotherapy-Induced Peripheral Neuropathy and New Therapeutic Targets: Preclinical Data of Drug Repositioning

  2022cites this paper
• Paclitaxel Inhibits KCNQ Channels in Primary Sensory Neurons to Initiate the Development of Painful Peripheral Neuropathy

  2022cites this paper
• Pretreatment with Zonisamide Mitigates Oxaliplatin-Induced Toxicity in Rat DRG Neurons and DRG Neuron–Schwann Cell Co-Cultures

  2022cites this paper
• Rational Design of a Novel Tubulin Inhibitor with a Unique Mechanism of Action

  2022cites this paper
• Ramipril Alleviates Oxaliplatin-Induced Acute Pain Syndrome in Mice

  2021cites this paper
• Platinum accumulation in oxaliplatin‐induced peripheral neuropathy

  2021cites this paper
• Probing the peripheral immune response in mouse models of oxaliplatin-induced peripheral neuropathy highlights their limited translatability

  2021cites this paper
• PEA-OXA Mitigates Oxaliplatin-Induced Painful Neuropathy through NF-κB/Nrf-2 Axis

  2021cites this paper
• In vitro and in vivo combinatorial anticancer effects of oxaliplatin- and resveratrol-loaded N,O-carboxymethyl chitosan nanoparticles against colorectal cancer.

  2021cites this paper
• Mini-Review: Mitochondrial dysfunction and chemotherapy-induced neuropathic pain

  2021cites this paper
• Huangqi Guizhi Wuwu Decoction can prevent and treat oxaliplatin-induced neuropathic pain by TNFα/IL-1β/IL-6/MAPK/NF-kB pathway

  2021cites this paper
• Behavior and electrophysiology studies of the peripheral neuropathy induced by individual and co-administration of paclitaxel and oxaliplatin in rat.

  2021cites this paper
• Targeting lysosomal cysteine protease cathepsin S reveals immunomodulatory therapeutic strategy for oxaliplatin-induced peripheral neuropathy

  2021cites this paper
• Epigenetics Involvement in Oxaliplatin-Induced Potassium Channel Transcriptional Downregulation and Hypersensitivity

  2021cites this paper
• Association between Low-Grade Chemotherapy-Induced Peripheral Neuropathy (CINP) and Survival in Patients with Metastatic Adenocarcinoma of the Pancreas

  2021cites this paper
• Pathological Mechanisms and Preventive Strategies of Oxaliplatin-Induced Peripheral Neuropathy

  2021cites this paper
• Small molecule targeting NaV1.7 via inhibition of the CRMP2-Ubc9 interaction reduces and prevents pain chronification in a mouse model of oxaliplatin-induced neuropathic pain

  2021cites this paper
• Network Pharmacology and Experimental Evidence Identify the Mechanism of Astragaloside IV in Oxaliplatin Neurotoxicity

  2021cites this paper
• The Class I HDAC Inhibitor, MS-275, Prevents Oxaliplatin-Induced Chronic Neuropathy and Potentiates Its Antiproliferative Activity in Mice

  2021cites this paper
• Drug Repositioning for the Prevention and Treatment of Chemotherapy-Induced Peripheral Neuropathy: A Mechanism- and Screening-Based Strategy

  2021cites this paper
• Electrophysiological Assessments in and in Rodent Models of Chemotherapy-Induced Painful Peripheral

  2021cites this paper
• Peripheral Neuropathy under Oncologic Therapies: A Literature Review on Pathogenetic Mechanisms

  2021cites this paper
• Melittin, a honeybee venom derived peptide for the treatment of chemotherapy-induced peripheral neuropathy

  2021cites this paper
• Novel Functionalized Amino Acids as Inhibitors of GABA Transporters with Analgesic Activity

  2021cites this paper
• Cutaneous Pain in Disorders Affecting Peripheral Nerves.

  2021cites this paper
• β2-adrenoreceptor agonist ameliorates mechanical allodynia in paclitaxel-induced neuropathic pain via induction of mitochondrial biogenesis.

  2021cites this paper
• Integrins protect sensory neurons in models of paclitaxel-induced peripheral sensory neuropathy

  2021cites this paper
• The effect of turmeric and curcumin on neuropathic pain behavioral response of CCI model in rats

  2020cites this paper
• Platinum-Based Drugs Cause Mitochondrial Dysfunction in Cultured Dorsal Root Ganglion Neurons

  2020cites this paper
• The active second-generation proteasome inhibitor oprozomib reverts the oxaliplatin-induced neuropathy symptoms.

  2020cites this paper
• Effects of paclitaxel on the viscoelastic properties of mouse sensory nerves.

  2020cites this paper
• Nasal administration of mesenchymal stem cells reverses chemotherapy-induced peripheral neuropathy in mice.

  2020cites this paper
• Sexual dimorphism in the contribution of neuroendocrine stress axes to oxaliplatin-induced painful peripheral neuropathy.

  2020cites this paper
• Enolate-forming compounds provide protection from platinum neurotoxicity.

  2020cites this paper
• Neurotoxicity of antineoplastic drugs: Mechanisms, susceptibility, and neuroprotective strategies.

  2020cites this paper
• Possible roles of mitochondrial dysfunction in neuropathy

  2020cites this paper
• Chemotherapy‐induced peripheral neuropathy: Identifying the research gaps and associated changes to clinical trial design

  2020cites this paper
• Molecular mechanism of electroacupuncture treatment on oxaliplatin-induced peripheral neurotoxicity in rats

  2020cites this paper
• Metformin reduces c-Fos and ATF3 expression in the dorsal root ganglia and protects against oxaliplatin-induced peripheral sensory neuropathy in mice.

  2019cites this paper
• Neuropathic Pain in Taxane-Induced Peripheral Neuropathy: Evidence for Exercise in Treatment

  2019cites this paper
• Searching for analgesic drug candidates alleviating oxaliplatin‐induced cold hypersensitivity in mice

  2019cites this paper
• Olesoxime in Neurodegenerative Diseases: Scrutinising a Promising Drug Candidate.

  2019cites this paper
• Interventional and preventive effects of aripiprazole and ceftriaxone used alone or in combination on oxaliplatin-induced tactile and cold allodynia in mice.

  2019cites this paper
• Bortezomib-induced aerobic glycolysis contributes to chemotherapy-induced painful peripheral neuropathy

  2019cites this paper
• Novel mouse GABA uptake inhibitors with enhanced inhibitory activity toward mGAT3/4 and their effect on pain threshold in mice.

  2019cites this paper
• Veliparib: a new therapeutic option in ovarian cancer?

  2019cites this paper
• Methods for in vivo studies in rodents of chemotherapy induced peripheral neuropathy.

  2019cites this paper
• The Efficacy of Acupuncture in Chemotherapy-Induced Peripheral Neuropathy: Systematic Review and Meta-Analysis

  2019cites this paper
• Mitochondrial dysfunction in the pathogenesis of chemotherapy-induced peripheral neuropathy.

  2019cites this paper
• Role of non-macrophage cell-derived HMGB1 in oxaliplatin-induced peripheral neuropathy and its prevention by the thrombin/thrombomodulin system in rodents: negative impact of anticoagulants

  2019cites this paper
• Protective effect of ibuprofen in a rat model of chronic oxaliplatin-induced peripheral neuropathy

  2019cites this paper
• Disulfide-crosslinked reduction-responsive Prodrug Micelles for On-demand Paclitaxel Release

  2019cites this paper
• Bortezomib and metformin opposingly regulate the expression of hypoxia-inducible factor alpha and the consequent development of chemotherapy-induced painful peripheral neuropathy

  2019cites this paper
• Mitochondriopathy: The unifying concept in distal neuropathies?

  2019cites this paper
• Peripheral Nervous System Toxicity Biomarkers

  2019cites this paper
• Cell-specific role of HDAC6 in chemotherapy-induced mechanical allodynia and loss of intraepidermal nerve fibers.

  2019influential citation
• MiR-30b-5p attenuates oxaliplatin-induced peripheral neuropathic pain through the voltage-gated sodium channel Nav1.6 in rats.

  2019cites this paper
• Neuroprotective Effects of an Aqueous Extract of Forsythia viridissima and Its Major Constituents on Oxaliplatin-Induced Peripheral Neuropathy

  2019cites this paper
• Prevention and Treatment for Chemotherapy-Induced Peripheral 
Neuropathy: Therapies Based on CIPN Mechanisms

  2019cites this paper
• Chemotherapie-induzierte periphere Neuropathie

  2018cites this paper
• Chemokine CCL2 and its receptor CCR2 in the dorsal root ganglion contribute to oxaliplatin-induced mechanical hypersensitivity

  2018cites this paper